BioMed Research International / 2014 / Article / Fig 4

Research Article

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition

Figure 4

AcSDKP inhibits EndMT in the diabetic kidney. ((a)–(e)) Immunolabeling for FSP1 and CD31 in a kidney from each group of mice. Arrows indicate cells that are double-labeled for FSP1 and CD31. ((f)–(j)) Immunolabeling for αSMA and CD31 in a kidney from each group of mice. Arrows indicate cells that are double-labeled for αSMA and CD31. Merged images with DAPI-stained nuclei are shown. Scale bar: 25 μm. ((k), (l)) Quantification of cells undergoing EndMT. FSP1 and CD31 double-labeled cells (k) and αSMA and CD31 double-labeled cells (l) in each visual field were imaged using fluorescence microscopy and quantified. The data are expressed as the mean ± SEM values. Diabetes is designated as DM. For all of the groups except the group that received TA-606 ( ), mice were analyzed.
696475.fig.004a
(a)
696475.fig.004b
(b)
696475.fig.004c
(c)
696475.fig.004d
(d)
696475.fig.004e
(e)
696475.fig.004f
(f)
696475.fig.004g
(g)
696475.fig.004h
(h)
696475.fig.004i
(i)
696475.fig.004j
(j)
696475.fig.004k
(k)
696475.fig.004l
(l)